Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • General
  • Hedge Funds
  • Long Ideas
  • Media
  • News
  • Top Stories
  • Trading Ideas

David Einhorn Sees ‘Increasingly Difficult’ Environment For Stocks, But He’s Betting On These 3 ‘Ridiculously Inexpensive’ Names

By Adam Eckert
Today, 10:30 PM
Greenlight Capital's David Einhorn is far from bullish, but he sees massive opportunity in a few value names the market has forgotten about. 

CEIX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Mizuho Maintains Buy on Tenet Healthcare, Raises Price Target to $78

By Benzinga Newsdesk
Today, 10:30 PM
Mizuho analyst Ann Hynes maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $60 to $78.

THC

Read More
2 minute read
  • Analyst Ratings

What 6 Analyst Ratings Have To Say About Tenet Healthcare

By Benzinga Insights
Today, 10:30 PM
Tenet Healthcare (NYSE:THC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

THC

Read More
11 minute read
  • Earnings

Earnings Scheduled For February 9, 2023

By Benzinga Insights
Today, 10:30 PM
Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.

ABBV

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $59

By Benzinga Newsdesk
Today, 10:30 PM
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $48 to $59.

THC

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
Today, 10:30 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

A

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Mizuho Maintains Buy on Tenet Healthcare, Lowers Price Target to $60

By Benzinga Newsdesk
Today, 10:30 PM
Mizuho analyst Ann Hynes maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $80 to $60.

THC

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

SVB Leerink Maintains Outperform on Tenet Healthcare, Lowers Price Target to $55

By Benzinga Newsdesk
Today, 10:30 PM
SVB Leerink analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and lowers the price target from $89 to $55.

THC

Read More
1 minute read
  • Analyst Ratings

Wells Fargo Maintains Overweight Rating for Tenet Healthcare: Here’s What You Need To Know

By Benzinga Insights
Today, 10:30 PM
Wells Fargo has decided to maintain its Overweight rating of Tenet Healthcare (NYSE:THC) and lower its price target from $82.00 to $48.00. Shares of Tenet Healthcare are trading up 3.95% over the last 24 hours, at $38.98 per share.

THC

Read More
1 minute read
  • Analyst Ratings

Expert Ratings for Tenet Healthcare

By Benzinga Insights
Today, 10:30 PM
Tenet Healthcare (NYSE:THC) has observed the following analyst ratings within the last quarter:

THC

Posts navigation

1 2 … 13 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service